Embedded within the Broad Institute , the Center for the Development of Therapeutics (CDoT) is a highly collaborative organization of professional drug discovery scientists. Our mission is to translate cutting-edge biological insights originating from the Broad community into impactful drug discovery projects. We partner with faculty from MIT, Harvard, and the Harvard teaching hospitals, along with industry partners in pharmaceutical, biotechnology and venture capital firms to validate druggable targets and identify leads. We combine our deep expertise in drug discovery with the knowledge and unique capabilities of the Broad Institute to address a wide range of disease areas (including oncology, cardiovascular, psychiatry, infectious and rare diseases). We use systematic approaches in genomics, biology, chemistry, and machine learning coupled with the Broad's culture of creativity, risk-taking, and open sharing, to successfully advance science and develop new treatments for patients. We are seeking an energetic and motivated Research Associate to be part of CDoT's Rapid Automated Binder Identification Technology (RABIT) platform. The ideal candidate is passionate about technology development and deeply appreciates operational efficiency, with a strong desire to work at scale using automation. Essential experience includes creating and utilizing affinity reagents (such as antibodies, scFvs, or nanobodies) across various display technologies (e.g., phage, yeast, or ribosome). The successful candidate will work closely with antibody engineers, automation engineers, biophysicists, data scientists, machine learning engineers, and subject matter experts to align and execute on platform goals. This position is a unique opportunity to help build a high-impact capability within the Broad.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level
Number of Employees
251-500 employees